Are you Dr. Bernath?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 43 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
100 N Academy Ave
Danville, PA 17822Phone+1 570-271-6045Fax+1 570-271-6542- Is this information wrong?
Summary
- Dr. Albert Bernath Jr., MD is an oncologist in Danville, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Geisinger Medical Center.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1974 - 1976
- Duke University HospitalResidency, Internal Medicine, 1972 - 1974
- University of Pittsburgh School of MedicineClass of 1972
Certifications & Licensure
- PA State Medical License 1976 - 2014
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor Start of enrollment: 2003 Jun 01
- Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2006 Feb 01
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsCorrection to: N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCC...Winston Tan, David W. Hillman, Muhammad Salim, Donald W. Northfelt, D. M. Anderson, P. J. Stella, R. D. Niedringhaus, Albert M. Bernath, S. S. Gamini, Frances M. Palmi...> ;Annals of Oncology. 2018 Jan 1
- 6 citationsPhase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic b...Winston Tan, Jacob B. Allred, Muhammad Salim, Patrick J. Flynn, Paul A. S. Fishkin, Philip J. Stella, Martin Wiesenfeld, Albert M. Bernath, Tom R. Fitch, Edith A. Perez> ;Clinical Breast Cancer. 2012 Apr 1
- 72 citationsIncreased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatmentRobert A. Schnoll, Elisa Martinez, Kristina L. Tatum, Marcella Glass, Albert M. Bernath, Daron G. Ferris, Patrick Reynolds> ;Addictive Behaviors. 2011 Jan 1
- Join now to see all
Grant Support
- Geisinger Clinical Oncology ProgramNational Cancer Institute1990–2010
- Geisinger Clinical Oncology ProgramNational Cancer Institute1987–2007
- Community Clinical Oncology ProgramNational Cancer Institute1985–1986
Hospital Affiliations
- Geisinger Medical CenterDanville, Pennsylvania